As a proof-of-principle, we chose CCND1 mRNA and SNHG5 lncRNA for qRT-PCR validation of whole transcriptome sequencing results of MCL cases as well as control group samples (Table S3). The gene discussed is CCND1; the disease is mantle cell lymphoma.